08:00 , Feb 26, 2007 |  BC Week In Review  |  Company News

Caden board of directors update

Caden Biosciences Inc. , Madison, Wis.   Business: Supply/Service, High throughput screening   Appointed: William Clarke, CEO of Cellectar LLC  ...
08:00 , Feb 19, 2007 |  BioCentury  |  Finance

Ebb & Flow

When Invitrogen bought BioReliance for $500 million in cash in early 2004, the rationale was clear: make a bioproduction powerhouse by coupling services with products. The deal combined IVGN's media, sera, reagents, packaging and cell...